Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 26,958Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ALFRED E TIEFENBACHER GmbH & Co KG

02 1ACCORD HEALTHCARE SLU

03 1ACTELION REGISTRATION LTD

04 1Acte Lion Registration Ltd

05 1Actelion Registration Ltd.

06 1Blue Fish Solvay AB

07 1Bluefish Pharmaceuticals AB

08 1DIPHARMA ARZNEIMITTEL GMBH

09 1Dipharma SA

10 1GEN.ORPH SAS

11 1JANSSEN CILAG INTERNATIONAL NV

12 1Janssen-Cilag AG

13 1PIRAMAL CRITICAL CARE BV

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Regulatory Info : Registered in EU

Registration Country : Germany

Miglustat

Brand Name :

Dosage Form : Hard Capsule

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Registered in EU

Registration Country : Germany

Tiefenbacher Compnay Banner

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Miglustat

Brand Name : MIGLUSTAT ACCORD

Dosage Form : Hard Capsules

Dosage Strength : 100 mg

Packaging : 84 UNITS 100 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

miglustat

Brand Name : Zavesca

Dosage Form : HARD CAPSULES

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Miglustat

Brand Name : Zavea

Dosage Form : Miglustat 100Mg 84 Combined Oral Use

Dosage Strength : 84 cps 100 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Miglustat

Brand Name : Zavesca

Dosage Form : Capsule, hard

Dosage Strength : 100 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

miglustat

Brand Name : Miglustat Bluefish

Dosage Form : KAPSEL, HÅRD

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Miglustat

Brand Name : MIGLUSTAT DIPHARMA

Dosage Form : Hard Capsule

Dosage Strength : 100 mg

Packaging : 84 UNITS 100 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Miglustat

Brand Name : ZAVESCA

Dosage Form : Hard Capsules

Dosage Strength : 100 mg

Packaging : 84 UNITS 100 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

Blue Fish Solvay AB

Country
2024 ACI Convention
Not Confirmed
arrow

Blue Fish Solvay AB

Country
arrow
2024 ACI Convention
Not Confirmed

Miglustat

Brand Name : Miglustat Blue Fish

Dosage Form : Capsule, hard

Dosage Strength : 100 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

10

GEN.ORPH SAS

Country
2024 ACI Convention
Not Confirmed
arrow

GEN.ORPH SAS

Country
arrow
2024 ACI Convention
Not Confirmed

Miglustat

Brand Name : MIGLUSTAT GEN ORPH

Dosage Form : Hard Capsule

Dosage Strength : 100 mg

Packaging : 84 UNITS 100 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank